ATE13487T1 - Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem polaren bioaktiven wirkstoff und einem hilfsstoff. - Google Patents
Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem polaren bioaktiven wirkstoff und einem hilfsstoff.Info
- Publication number
- ATE13487T1 ATE13487T1 AT81101644T AT81101644T ATE13487T1 AT E13487 T1 ATE13487 T1 AT E13487T1 AT 81101644 T AT81101644 T AT 81101644T AT 81101644 T AT81101644 T AT 81101644T AT E13487 T1 ATE13487 T1 AT E13487T1
- Authority
- AT
- Austria
- Prior art keywords
- polar bioactive
- excipients
- bioactive agents
- polar
- oral use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/27—Cyclic peptide or cyclic protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12810180A | 1980-03-07 | 1980-03-07 | |
EP81101644A EP0036145B1 (de) | 1980-03-07 | 1981-03-06 | Arzneimittelformulierung zur oralen Verabreichung mit Gehalt an einem polaren bioaktiven Wirkstoff und einem Hilfsstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE13487T1 true ATE13487T1 (de) | 1985-06-15 |
Family
ID=22433643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT81101644T ATE13487T1 (de) | 1980-03-07 | 1981-03-06 | Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem polaren bioaktiven wirkstoff und einem hilfsstoff. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4462991A (de) |
EP (1) | EP0036145B1 (de) |
JP (1) | JPS56166849A (de) |
AT (1) | ATE13487T1 (de) |
AU (1) | AU556734B2 (de) |
CA (1) | CA1165689A (de) |
DE (1) | DE3170684D1 (de) |
DK (1) | DK102181A (de) |
ES (1) | ES500186A0 (de) |
GR (1) | GR74442B (de) |
IE (1) | IE50984B1 (de) |
NZ (1) | NZ196349A (de) |
PT (1) | PT72576B (de) |
ZA (1) | ZA811515B (de) |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU541247B2 (en) * | 1979-12-20 | 1985-01-03 | R.P. Scherer Corporation | Adjuvants for rectal delivery of drug substances |
GR75219B (de) * | 1980-04-21 | 1984-07-13 | Merck & Co Inc | |
JPS57188526A (en) * | 1981-05-14 | 1982-11-19 | Takeda Chem Ind Ltd | Peptide-containing pharmaceutical preparation |
BE896711A (fr) * | 1982-05-14 | 1983-09-01 | Richter Gedeon Vegyeszet | Compositions pharmaceutiques anti-ulceres. |
US4508706A (en) * | 1983-03-30 | 1985-04-02 | Yale University | Composition for increasing melanin in mammalian skin and hair |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
DE3331009A1 (de) * | 1983-08-27 | 1985-03-14 | Basf Ag, 6700 Ludwigshafen | Verfahren zur erhoehung der enteralen resorbierbarkeit von heparin bzw. heparinoiden sowie das so erhaeltliche heparin- bzw. heparinoidpraeparat |
JPS6061523A (ja) * | 1983-09-16 | 1985-04-09 | Shionogi & Co Ltd | 経口用ドブタミン製剤 |
US4703042A (en) * | 1984-05-21 | 1987-10-27 | Bodor Nicholas S | Orally active heparin salts containing multivalent cationic units |
EP0177342A3 (de) * | 1984-10-04 | 1987-12-02 | Genentech, Inc. | Orale Formulierungen therapeutischer Proteine |
US4729989A (en) * | 1985-06-28 | 1988-03-08 | Merck & Co., Inc. | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts |
US4822773A (en) * | 1985-06-28 | 1989-04-18 | Merck & Co., Inc. | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts |
US4692441A (en) * | 1985-08-16 | 1987-09-08 | Merck & Co., Inc. | Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities |
IL77186A0 (en) * | 1985-11-29 | 1986-04-29 | Touitou Elka | Pharmaceutical insulin composition |
US4983400A (en) * | 1986-06-16 | 1991-01-08 | Merck & Co., Inc. | Controlled release combination of carbidopa/levodopa |
CA1323833C (en) * | 1987-04-28 | 1993-11-02 | Yatindra M. Joshi | Pharmaceutical compositions in the form of beadlets and method |
US5167947A (en) * | 1989-10-26 | 1992-12-01 | Southwest Research Institute | Enhancement of absorption of radioprotective drugs |
US5443841A (en) * | 1992-06-15 | 1995-08-22 | Emisphere Technologies, Inc. | Proteinoid microspheres and methods for preparation and use thereof |
US6221367B1 (en) | 1992-06-15 | 2001-04-24 | Emisphere Technologies, Inc. | Active agent transport systems |
US5541155A (en) * | 1994-04-22 | 1996-07-30 | Emisphere Technologies, Inc. | Acids and acid salts and their use in delivery systems |
US5629020A (en) * | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
US5578323A (en) * | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
US5693338A (en) * | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
US5714167A (en) * | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
US6344213B1 (en) | 1996-03-29 | 2002-02-05 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6099856A (en) * | 1992-06-15 | 2000-08-08 | Emisphere Technologies, Inc. | Active agent transport systems |
CA2050425A1 (en) * | 1990-09-03 | 1992-03-04 | Yoshiaki Uda | Pharmaceutical composition and its mucous use |
US5811127A (en) * | 1992-06-15 | 1998-09-22 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
US6916489B2 (en) * | 1992-06-15 | 2005-07-12 | Emisphere Technologies, Inc. | Active agent transport systems |
US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
US5401516A (en) * | 1992-12-21 | 1995-03-28 | Emisphere Technologies, Inc. | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
US6610329B2 (en) | 1993-04-22 | 2003-08-26 | Emisphere Technologies Inc. | Compositions for the delivery of antigens |
DE69428040T2 (de) * | 1993-04-22 | 2002-05-29 | Emisphere Technologies, Inc. | Orale darreichungsform |
US5709861A (en) * | 1993-04-22 | 1998-01-20 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
US5958457A (en) * | 1993-04-22 | 1999-09-28 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
US20010003001A1 (en) | 1993-04-22 | 2001-06-07 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5643957A (en) * | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5424289A (en) * | 1993-07-30 | 1995-06-13 | Alza Corporation | Solid formulations of therapeutic proteins for gastrointestinal delivery |
US6090958A (en) * | 1995-03-31 | 2000-07-18 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5866536A (en) * | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6001347A (en) | 1995-03-31 | 1999-12-14 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
CN1151836C (zh) * | 1995-03-31 | 2004-06-02 | 艾米斯菲尔技术有限公司 | 用作传送活性剂的化合物和组合物 |
US5989539A (en) * | 1995-03-31 | 1999-11-23 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5965121A (en) * | 1995-03-31 | 1999-10-12 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5650386A (en) * | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
US5820881A (en) * | 1995-04-28 | 1998-10-13 | Emisphere Technologies, Inc. | Microspheres of diamide-dicarboxylic acids |
US6051258A (en) * | 1995-06-07 | 2000-04-18 | Emisphere Technologies, Inc. | Proteinoid emulsions and methods for preparation and use thereof |
US5667806A (en) * | 1995-06-07 | 1997-09-16 | Emisphere Technologies, Inc. | Spray drying method and apparatus |
US5750147A (en) | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
US5824345A (en) * | 1995-06-07 | 1998-10-20 | Emisphere Technologies, Inc. | Fragrances and flavorants |
GB2320248B (en) * | 1995-09-11 | 1999-04-14 | Emisphere Tech Inc | Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones |
EP0904065A4 (de) | 1996-06-14 | 2000-06-14 | Emisphere Tech Inc | Mikroverkapselte duftstoffe und herstellungsverfahren |
US6391303B1 (en) | 1996-11-18 | 2002-05-21 | Emisphere Technologies, Inc. | Methods and compositions for inducing oral tolerance in mammals |
PA8444901A1 (es) * | 1997-01-28 | 2000-05-24 | Hoffmann La Roche | Derivados de 5-aroilnaftaleno como agentes anti-inflamatorios |
US5990166A (en) * | 1997-02-07 | 1999-11-23 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5876710A (en) * | 1997-02-07 | 1999-03-02 | Emisphere Technologies Inc. | Compounds and compositions for delivering active agents |
US6358504B1 (en) | 1997-02-07 | 2002-03-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5804688A (en) * | 1997-02-07 | 1998-09-08 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6060513A (en) * | 1997-02-07 | 2000-05-09 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6313088B1 (en) | 1997-02-07 | 2001-11-06 | Emisphere Technologies, Inc. | 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents |
US5879681A (en) * | 1997-02-07 | 1999-03-09 | Emisphere Technolgies Inc. | Compounds and compositions for delivering active agents |
US5939381A (en) * | 1997-02-07 | 1999-08-17 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5863944A (en) * | 1997-04-30 | 1999-01-26 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5962710A (en) * | 1997-05-09 | 1999-10-05 | Emisphere Technologies, Inc. | Method of preparing salicyloylamino acids |
DE69830185D1 (de) | 1997-05-19 | 2005-06-16 | Repligen Corp | Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen |
US6197746B1 (en) * | 1998-05-19 | 2001-03-06 | Repligen Corporation | Method of using secretin for treating autism |
US6440929B1 (en) | 1998-07-27 | 2002-08-27 | Emisphere Technologies, Inc. | Pulmonary delivery of active agents |
KR20010074777A (ko) | 1998-07-27 | 2001-08-09 | 추후제출 | 활성제의 폐를 통한 전달 |
US6991798B1 (en) | 1998-08-07 | 2006-01-31 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
ATE329897T1 (de) | 1998-08-07 | 2006-07-15 | Emisphere Tech Inc | Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen |
JP2002534363A (ja) | 1999-01-08 | 2002-10-15 | エミスフェアー・テクノロジーズ・インク | ポリマー性デリバリー剤及びデリバリー剤化合物 |
US6761903B2 (en) | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
AU3378100A (en) | 1999-02-26 | 2000-09-14 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
JP4588221B2 (ja) | 1999-04-05 | 2010-11-24 | エミスフェアー・テクノロジーズ・インク | 活性剤を送達するための二ナトリウム塩、一水和物、およびエタノール溶媒和物 |
US6458383B2 (en) | 1999-08-17 | 2002-10-01 | Lipocine, Inc. | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
US7279597B1 (en) | 1999-11-05 | 2007-10-09 | Emisphere Technologies, Inc. | Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
US7129274B1 (en) | 1999-11-05 | 2006-10-31 | Emisphere Technologies Inc. | Phenoxy carboxylic acid compounds and compositions for delivering active agents |
EP1237872B1 (de) * | 1999-12-16 | 2008-02-27 | Emisphere Technologies, Inc. | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe |
JP4879433B2 (ja) | 2000-01-13 | 2012-02-22 | エミスフェアー・テクノロジーズ・インク | 活性剤を送達するための化合物および組成物 |
ATE391708T1 (de) | 2000-06-29 | 2008-04-15 | Emisphere Tech Inc | Verbindungen und gemische zur verabreichung eines aktiven agens |
US20040109920A1 (en) * | 2002-12-04 | 2004-06-10 | Bioactives Llc | Coated carotenoid cyclodextrin complexes |
JP2005209106A (ja) * | 2004-01-26 | 2005-08-04 | Nec Corp | 携帯通信端末、受信メール管理方法、プログラムおよび記録媒体 |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
EP3544614A4 (de) | 2016-11-28 | 2020-08-05 | Lipocine Inc. | Orale testosteron-undecanoat-therapie |
EP4222502A1 (de) * | 2020-09-29 | 2023-08-09 | F. Hoffmann-La Roche AG | Verfahren zur bestimmung des vitamin-d-spiegels und metaboliten davon |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE340744C (de) * | 1916-08-04 | 1921-09-20 | Knoll & Co | Verfahren zur Darstellung neutral loeslicher Doppelverbindungen von Dialkylxanthinen sowie von ihren N-Acidylderivaten |
GB905092A (en) * | 1959-07-10 | 1962-09-05 | American Cyanamid Co | Improved tetracycline antibiotic compositions |
US3159537A (en) * | 1960-12-20 | 1964-12-01 | American Cyanamid Co | Potentiation of tetracycline by phosphinic acid |
GB1285361A (en) * | 1969-04-18 | 1972-08-16 | Rech S Et D Applic Scient Et M | Improvements in or relating to pyrazolidine derivatives |
FR2124101A1 (en) * | 1971-02-05 | 1972-09-22 | Merck & Co Inc | Sleep-inducing compns contng salicylamide - and glyceryl guaiacolate |
FR2258171A1 (en) * | 1974-01-21 | 1975-08-18 | Aries Robert | Oral male contraceptives - comprising steroidal progestogens potentiated with hydroxybenzoic acids |
HU170329B (de) * | 1974-12-12 | 1977-05-28 | ||
FR2379285A2 (fr) * | 1977-02-08 | 1978-09-01 | Expl Marques Brevets Et | Nouvelle composition a base d'acide salicylique et de corticoide |
JPS56122310A (en) * | 1980-03-03 | 1981-09-25 | Teijin Ltd | Suppository |
-
1981
- 1981-02-25 NZ NZ196349A patent/NZ196349A/en unknown
- 1981-02-26 PT PT72576A patent/PT72576B/pt not_active IP Right Cessation
- 1981-03-03 IE IE454/81A patent/IE50984B1/en not_active IP Right Cessation
- 1981-03-04 GR GR64314A patent/GR74442B/el unknown
- 1981-03-04 AU AU68057/81A patent/AU556734B2/en not_active Ceased
- 1981-03-05 CA CA000372394A patent/CA1165689A/en not_active Expired
- 1981-03-06 ES ES500186A patent/ES500186A0/es active Granted
- 1981-03-06 ZA ZA00811515A patent/ZA811515B/xx unknown
- 1981-03-06 AT AT81101644T patent/ATE13487T1/de active
- 1981-03-06 DE DE8181101644T patent/DE3170684D1/de not_active Expired
- 1981-03-06 DK DK102181A patent/DK102181A/da not_active Application Discontinuation
- 1981-03-06 EP EP81101644A patent/EP0036145B1/de not_active Expired
- 1981-03-07 JP JP3194281A patent/JPS56166849A/ja active Pending
-
1982
- 1982-06-11 US US06/387,410 patent/US4462991A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU6805781A (en) | 1981-09-17 |
PT72576A (en) | 1981-03-01 |
AU556734B2 (en) | 1986-11-20 |
ES8301632A1 (es) | 1983-01-01 |
ES500186A0 (es) | 1983-01-01 |
DE3170684D1 (en) | 1985-07-04 |
CA1165689A (en) | 1984-04-17 |
IE50984B1 (en) | 1986-09-03 |
EP0036145A1 (de) | 1981-09-23 |
JPS56166849A (en) | 1981-12-22 |
DK102181A (da) | 1981-09-08 |
NZ196349A (en) | 1984-08-24 |
US4462991A (en) | 1984-07-31 |
GR74442B (de) | 1984-06-28 |
IE810454L (en) | 1981-09-07 |
PT72576B (en) | 1985-11-25 |
EP0036145B1 (de) | 1985-05-29 |
ZA811515B (en) | 1982-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE13487T1 (de) | Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem polaren bioaktiven wirkstoff und einem hilfsstoff. | |
IT1140521B (it) | Sistema medicinale da somministrare per via intradermica per dinitrato di isosorbite | |
NO820742L (no) | Fremgangsmaate for fremstilling av stabiliserte insulinpreparater | |
ATA21888A (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken | |
SE7707462L (sv) | Forfarande for framstellning av penicillansyraderivat | |
IT7849754A0 (it) | Dispositivo per la somministrazione di sostanze medicamentose in particolare ad animali | |
ATE29837T1 (de) | Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem beta-lactam-antibiotikum und einem hilfsstoff. | |
DK543380A (da) | Laegemiddelformulering fremgangsmaade til fremstilling deraf og adjuvans til brug ved fremgangsmaaden | |
DK429480A (da) | Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel | |
DE2965732D1 (en) | Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition | |
NO810480L (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater | |
ATE24398T1 (de) | Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem glycosid antibiotikum und einem hilfsstoff. | |
ATE96670T1 (de) | Arzneimittel auf dextrorphanbasis zur intranasalen applikation. | |
FR2273530A2 (fr) | Nouveaux acides et sels cyanophenylene-dioxamiques, leur procede de preparation et medicament les contenant | |
GB2019720A (en) | S-adenosyl-L-homocysteine and salts thereof for use in therapy | |
DE2960927D1 (en) | N1-benzoyl-n2-phenyl-1,3-diaminopropane-2-ols and their salts, process for their preparation and medicaments containing them | |
ZA824649B (en) | New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds | |
BE768813A (fr) | Acides aminoalkanoiques substitues, leurs sels acceptables pourl'usage pharmaceutique, leur preparation et leurs utilisations therapeutiques | |
IT7945204A0 (it) | Composizione farmaceutica per la terapia delle sterilita' maschile |